These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24687730)

  • 41. Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.
    Senders ML; Hernot S; Carlucci G; van de Voort JC; Fay F; Calcagno C; Tang J; Alaarg A; Zhao Y; Ishino S; Palmisano A; Boeykens G; Meerwaldt AE; Sanchez-Gaytan BL; Baxter S; Zendman L; Lobatto ME; Karakatsanis NA; Robson PM; Broisat A; Raes G; Lewis JS; Tsimikas S; Reiner T; Fayad ZA; Devoogdt N; Mulder WJM; Pérez-Medina C
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):2015-2026. PubMed ID: 30343086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive detection of matrix metalloproteinase-9 in atherosclerotic lesions using technetium-99m-labeled single-photon emission computed tomography in vivo.
    Wang Z; Deng G; Zhang Z; Huang H; Zhao Y
    Nucl Med Commun; 2017 Apr; 38(4):299-305. PubMed ID: 28234785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
    Ayala-López W; Xia W; Varghese B; Low PS
    J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
    Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
    J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-9 overexpression suppresses vulnerable atherosclerotic plaque and enhances vascular remodeling through negative regulation of the p38MAPK pathway via OLR1 in acute coronary syndrome.
    Yu DR; Wang T; Huang J; Fang XY; Fan HF; Yi GH; Liu Q; Zhang Y; Zeng XZ; Liu QB
    J Cell Biochem; 2020 Jan; 121(1):49-62. PubMed ID: 31571264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.
    Nie X; Randolph GJ; Elvington A; Bandara N; Zheleznyak A; Gropler RJ; Woodard PK; Lapi SE
    Nucl Med Biol; 2016 Sep; 43(9):534-542. PubMed ID: 27372286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (
    Varasteh Z; De Rose F; Mohanta S; Li Y; Zhang X; Miritsch B; Scafetta G; Yin C; Sager HB; Glasl S; Gorpas D; Habenicht AJR; Ntziachristos V; Weber WA; Bartolazzi A; Schwaiger M; D'Alessandria C
    Theranostics; 2021; 11(4):1864-1876. PubMed ID: 33408786
    [No Abstract]   [Full Text] [Related]  

  • 49. Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
    Meletta R; Slavik R; Mu L; Rancic Z; Borel N; Schibli R; Ametamey SM; Krämer SD; Müller Herde A
    Nucl Med Biol; 2017 Apr; 47():31-43. PubMed ID: 28104528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies.
    Fiechter M; Frey K; Fugmann T; Kaufmann PA; Neri D
    Atherosclerosis; 2011 Feb; 214(2):325-30. PubMed ID: 21167484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging.
    Ogawa M; Umeda IO; Kosugi M; Kawai A; Hamaya Y; Takashima M; Yin H; Kudoh T; Seno M; Magata Y
    J Nucl Med; 2014 Jan; 55(1):115-20. PubMed ID: 24337605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice.
    Broisat A; Toczek J; Dumas LS; Ahmadi M; Bacot S; Perret P; Slimani L; Barone-Rochette G; Soubies A; Devoogdt N; Lahoutte T; Fagret D; Riou LM; Ghezzi C
    J Nucl Med; 2014 Oct; 55(10):1678-84. PubMed ID: 25157043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages.
    Koga M; Kanaoka Y; Inada K; Omine S; Kataoka Y; Yamauchi A
    J Pharmacol Sci; 2020 Jun; 143(2):106-111. PubMed ID: 32173266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.
    Lee GY; Kim JH; Oh GT; Lee BH; Kwon IC; Kim IS
    J Control Release; 2011 Oct; 155(2):211-7. PubMed ID: 21781994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preclinical evaluation of an
    Park JY; Kim HJ; Chae JR; Cho YL; Kang WJ
    Biochem Biophys Res Commun; 2024 Apr; 703():149650. PubMed ID: 38377941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).
    Liu Z; Xu S; Huang X; Wang J; Gao S; Li H; Zhou C; Ye J; Chen S; Jin ZG; Liu P
    Br J Pharmacol; 2015 Dec; 172(23):5661-75. PubMed ID: 25572313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization of deoxyglucose and annexin A5 in experimental atheroma correlates with macrophage infiltration but not lipid deposition in the lesion.
    Zhao Y; Zhao S; Kuge Y; Strauss WH; Blankenberg FG; Tamaki N
    Mol Imaging Biol; 2011 Aug; 13(4):712-20. PubMed ID: 20686858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using
    Varasteh Z; Hyafil F; Anizan N; Diallo D; Aid-Launais R; Mohanta S; Li Y; Braeuer M; Steiger K; Vigne J; Qin Z; Nekolla SG; Fabre JE; Döring Y; Le Guludec D; Habenicht A; Vera DR; Schwaiger M
    EJNMMI Res; 2017 Dec; 7(1):40. PubMed ID: 28470406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.
    Matter CM; Schuler PK; Alessi P; Meier P; Ricci R; Zhang D; Halin C; Castellani P; Zardi L; Hofer CK; Montani M; Neri D; Lüscher TF
    Circ Res; 2004 Dec; 95(12):1225-33. PubMed ID: 15539632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic Efficacy of
    Dekempeneer Y; Caveliers V; Ooms M; Maertens D; Gysemans M; Lahoutte T; Xavier C; Lecocq Q; Maes K; Covens P; Miller BW; Bruchertseifer F; Morgenstern A; Cardinaels T; D'Huyvetter M
    Mol Pharm; 2020 Sep; 17(9):3553-3566. PubMed ID: 32787284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.